Vital Health Sciences and Zila strike deal for Vitamin E product.

According to the Age ( Vital Health Sciences, soon to become entirely owned by venture capital firm Vital Capital, has struck a deal with Zila Inc., to license Vital's vitamin E product in a soon to be launched product, Ester-E.

According to the deal, Zila will pay an up front fee of $500,000 and Vital Health Sciences will also receive 10 percent to 17 percent royalty payments with a minimum assured to guarantee Zila the exclusivity.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.